Article
Ivermectin as an inhibitor of cancer stem‑like cells
8 Dec 2017
Abstract excerpt
The aim of the present study was to demonstrate that ivermectin preferentially inhibited cancer stem‑like cells (CSC) in breast cancer cells and downregulated the expression of 'stemness' genes. Computational searching of DrugBank, a database of approved drugs, was performed using the principles of two‑dimensional similarity searching; the chemical structure of salinomycin was used as a query. Growth inhibition...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
